Title: A  Study on Incidence and Analysis of Carcinoma of Breast in Early Stage in Tertiary Care Hospital

Authors: Dr M. Sukriya M.S, Dr P. Mahesh Kumar. M.S

 DOI: https://dx.doi.org/10.18535/jmscr/v7i3.62

Abstract

Introduction

Worldwide, Breast cancer is by far the most common cancer amongst women with an incidence rate more than twice that of colorectal cancer and cervical cancer and about three times that of lung cancer.1,23,4. The incidence of breast cancer in India is on the rise and is rapidly, becoming the number one cancer in females pushing the cervical cancer to second place.5,6,7,8

It is reported that one in 22 women in India is likely to suffer from breast cancer during her lifetime while the figure is definitely more in America where eight being victim of this deadly cancer. The problem with preventing breast cancer is that there is no one cause that can be pinpointed as being the culprit. Of course screening for the presence of BRCA – 1, BRCA – 2 mutations in available, though it must be admitted of being little use in the Indian context.9,10,11,12

References

  1. Courtney M. Townsend, JR., MD., Sally Abston, M.D., Sally Abston, M.D., Jay C.Fish, Md. Surgical Adjuvant Treatment of Locally Advanced Breast Cancer Ann. Surg May 1985 Vol 201 *No.5.
  2. Jackson VP. Diagnostic mammography. Radiolclin North Am 2004; 42(5):852, vi.
  3. Anderson, EDC. Treatment of breast recurrence after breast conservation. In; Dixon JM, SacchiniV.Dixin, eds. Breast cancer, diagnosis and management. 2000:43:1.
  4. Vallasiadou K. Young OE, Dixon JM. Current practices inbreast conservation surgery; results of a questionnaire. Br JSurg 2003; 90(1) :44.
  5. Sharon H. Giordano Update on Locally Advanced Breast Cancer the Oncologist, V 01.8.No.6, 521-530, December 2003.
  6. Shenkier, T, Weir L, Levine, M, Olivotto I , Whelan T, Reyno L; Steering committee on Clinical Practice Guidelines for the car and Treatment of Breast Cancer, CMAJ 2004 Mar 16:170(6):983-94
  7. Lyman GH, G iulano AE, Somerfield MR, et al. ASCOI guideline recommendations for sentinel lymph node biopsy in early stage breast cancer, J. ClinOncol 2005; 23:7703.
  8. Giuliano AE, Kirgan DM, Guenther JM, et al. LYMPHATIC MAPPING and sentinel lymphadenectomy for breast cancer.  Ann Surg 1994;220:391.
  9. Fletcher SW, Elmore JG.Mammographic screening for breast cancer, N Eng J Med 2003;348:1672.
  10. Haagensen CD Stout AP. Carcinoma of the breast. H . Criteria of operability.  Ann Surg 1943:118:857-870, 1032-1054.
  11. Rubens RD. the management of locally advanced breast cancer Br.J Cancer 1992; 65:145-147.
  12. Hortobagyi GN, Buzdar AU Locally advanced breast cancer; a review including the MD Anderson experience, In :Ragaz J, Ariel IM, eds. High – Risk Breast Cancer, Berlin: Springer – verlag, 1991: 382-415.
  13. A Budrukkar A, Dinshaw K, Jalali. R. management of Locally advanced breast cancer: Evolution & current practiced J.Caner Res Ther – Mar 2005, 1:21-30.
  14. Touboul E, Lefrance JP, Blondon J, Ozsahim M, Mauban S, Scheartz LH, Schlienger M, Laugier A, Guerin RA. Multidisciplinary treatment approach to locally advanced non-inflammatory breast cacer using chemotherapy and radiotherapy with or without surgery. Radiother Oncol, 1992 Nov:25 (3): 167-75.
  15. Kim R. Osaki A, Tanabe K, Toge T. Neoadjuvant chemotheraphy for locally advanced breast cancer with stage 3 HIB Oncol Rep. 2004 Jun: 11(6): 1265-72.
  16. Ahern V, Barraclough B, Bosch C, Langlands A, Boyages J. Locally advanced breast cancer: defining an optimum treatment regimen Int J RadiatOncolBiol Phys.  1994 Mar 1:28(4): 867-75.
  17. Eniu A, Carlson RW. Azoz Z. Bines J, Hortobagyi GN, Bese NS, Love RR, Vikram B, Kurkure A, Anderson BO Breast cancer in limited-resource countries: treatment and allocation of resources Breast J 2006 Jan _ Feb; 12 Supp1 1:S38-53.
  18. Beenken SW, Bland KI. Breast cancer genetics. In: Ellis CN, ed.Inherited cancer syndromes:current clinical management. Newyork:2004:91.
  19. Bland KI, Chang HR, Chandler GS, et al. MRM nadSM. In Bland KI, Copeland EM III, eds. The breast:  comprehensive managemebt of benign and malignant disorders.  WB Saunders, 2004:865.
  20. Jay r. harrist, Marc E.Lippman, Monica Morrow C. Kent Osborne, Diseases of the Brest 4thM.D. Anderson Cancer Center experience J ClinOncol 2001:19;628.       
  21. Veronesi U, Bonadonna G. ZurridaS,et al. Conservation surgery after primary chemotherapy in large carcinomas of the breast Ann Surg 1995;612.
  22. Valagussa P, Zambetti M, Bignami Pet al T3b-T4 breast cancer; factor affecting results in combined modality treatments, ClinExp Metastasis. 1983;1:191-202.
  23. Taylor G, Meltzer A Inflammatory carcinoma of the breast American Journal of Cancer 1938:33;33.
  24. Cariati, T.M. Bennett-Britton, S.E. Pinder, A.D. Purushotham Inflammatory “breast cancer surgical oncology 14(20050 133-143.

Corresponding Author

Dr P. Mahesh Kumar. M.S

Senior Assistant Professor, Govt Sivagangai Medical College, Sivagangai, India